Anti-tumor Properties of Prunella vulgaris

被引:0
|
作者
Huang M. [1 ,2 ]
Wang Y. [2 ]
Xu L. [1 ]
You M. [2 ]
机构
[1] Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Rd, Shanghai
[2] Medical College of Wisconsin Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, 53226, WI
关键词
Cancer; Chemoprevention; Chinese herbs; Prunella vulgaris;
D O I
10.1007/s40495-015-0038-6
中图分类号
学科分类号
摘要
Cancer is one of the most serious threats to public health around the world. Efforts in developing new therapies and prevention strategies are clearly insufficient in the face of a dramatically rising disease burden worldwide. New evaluation of alternate strategies, including those based on traditional medicine, is increasingly needed. These therapeutic or prevention approaches could prove complementary to current medical practice or could potentially aid in the development of new classes of pharmaceutical drugs with anti-cancer properties. Prunella vulgaris, a perennial herb, is a representative Chinese herb that has been put into practice to treat various types of diseases, including cancer. The triterpenoid, flavonoids, and phenylpropanoids in P. vulgaris have shown a collective therapeutic effect against cancer mediated through multiple pathways. This review discusses the chemical constituents of P. vulgaris, summarizes all of the known formulas that contain P. vulgaris, and also discusses in vitro, in vivo, and clinical studies on the anti-tumor properties of P. vulgaris. The aim is to bring better insights regarding P. vulgaris as an effective complementary method for treating cancer. Highlighted throughout this review is the necessity for additional prospective clinical trials on anti-tumor properties of P. vulgaris. © 2015, Springer International Publishing AG.
引用
收藏
页码:401 / 419
页数:18
相关论文
共 50 条
  • [41] Potentiating anti-tumor immunity with physical plasma
    Bekeschus, Sander
    Clemen, Ramona
    Metelmann, Hans-Robert
    CLINICAL PLASMA MEDICINE, 2018, 12 : 17 - 22
  • [42] Anti-tumor effects of perphenazine on canine lymphoma
    Tsuji, Shunya
    Yabe, Ryotaro
    Usui, Tatsuya
    Mizuno, Takuya
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (08) : 1293 - 1298
  • [43] Metabolic engineering to facilitate anti-tumor immunity
    Schild, Tanya
    Wallisch, Patrick
    Zhao, Yixuan
    Wang, Ya-Ting
    Haughton, Lyric
    Chirayil, Rachel
    Pierpont, Kaitlyn
    Chen, Kevin
    Nunes-Violante, Sara
    Cross, Justin
    de Stanchina, Elisa
    Thompson, Craig B.
    Scheinberg, David A.
    Perry, Justin S. A.
    Keshari, Kayvan R.
    CANCER CELL, 2025, 43 (03) : 552 - 562.e9
  • [44] Research progress on the anti-tumor effect of Naringin
    He, Jing
    Zhang, Hui-Ping
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [45] Metallothioneins and Platinum(II) Anti-Tumor Compounds
    Knipp, Markus
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (05) : 522 - 537
  • [46] Molecular Mechanism of Deguelin in Anti-tumor Effect
    Wen, Lu
    Chen, Yan
    CURRENT PHARMACEUTICAL ANALYSIS, 2012, 8 (01) : 14 - 19
  • [47] Trypsinogen and chymotrypsinogen: potent anti-tumor agents
    Gonzalez-Titos, Aitor
    Hernandez-Camarero, Pablo
    Barungi, Shivan
    Marchal, Juan Antonio
    Kenyon, Julian
    Peran, Macarena
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1609 - 1621
  • [48] Tumorigenesis and anti-tumor immune responses in Xenopus
    Goyos, Ana
    Robert, Jacques
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 167 - 176
  • [49] Advances in the anti-tumor mechanisms of saikosaponin D
    Jia, Ruixue
    Meng, Dandan
    Geng, Wei
    PHARMACOLOGICAL REPORTS, 2024, 76 (04) : 780 - 792
  • [50] Polysaccharides as Potential Anti-tumor Biomacromolecules -A Review
    Guo, Rui
    Chen, Min
    Ding, Yangyang
    Yang, Pengyao
    Wang, Mengjiao
    Zhang, Haihui
    He, Yuanqing
    Ma, Haile
    FRONTIERS IN NUTRITION, 2022, 9